PharmaCyte Biotech, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| K2 PRINCIPAL FUND, L.P. | 11/15/2024 | 209,266 | $399,698 | -36.10% | 2.66% |
| VANGUARD GROUP INC | 11/13/2024 | 192,387 | $367,459 | 0.00% | 2.45% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 168,200 | $321,286 | -4.76% | 2.14% |
| EQUITEC PROPRIETARY MARKETS, LLC | 10/18/2024 | 82,727 | $158,009 | 0.00% | 1.05% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 49,700 | $94,927 | 2.47% | 0.63% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 35,228 | $67,285 | -35.76% | 0.45% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 27,601 | $52,718 | 7.83% | 0.35% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 25,900 | $49,469 | 9.28% | 0.33% |
| UBS GROUP AG | 11/14/2024 | 8,354 | $15,957 | -69.70% | 0.11% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 2,860 | $5,463 | -61.27% | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 2,851 | $5,000 | 0.00% | 0.04% |
| ASPIRE PRIVATE CAPITAL, LLC | 10/25/2024 | 800 | $1,528 | 0.00% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 508 | $969 | -0.97% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 117 | $223 | -23.03% | 0.00% |
| PLANNING CAPITAL MANAGEMENT CORP | 11/06/2024 | 100 | $191 | 0.00% | 0.00% |
| MARYLAND CAPITAL ADVISORS INC. | 10/22/2024 | 35 | $68 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 12/26/2024 | 18 | $34 | -5.26% | 0.00% |
| SACHETTA, LLC | 11/08/2024 | 14 | $28 | 0.00% | 0.00% |
| BFSG, LLC | 10/16/2024 | 5 | $10 | 0.00% | 0.00% |
| MORGAN STANLEY | 11/14/2024 | 2 | $5 | -33.33% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 11/12/2024 | 2 | $4 | 100.00% | 0.00% |
| NEWEDGE ADVISORS, LLC | 11/14/2024 | 2 | $4 | 0.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| KELLY FINANCIAL SERVICES LLC | 10/09/2024 | 0 | $0 | -100.00% | 0.00% |
PharmaCyte Biotech, Inc.institutional Ownership - FAQ's
During the previous two years, 27 institutional investors and hedge funds held shares of PharmaCyte Biotech, Inc.. The most heavily invested institutionals were:
K2 PRINCIPAL FUND, L.P.: 209,266
VANGUARD GROUP INC: 192,387
GEODE CAPITAL MANAGEMENT, LLC: 168,200
EQUITEC PROPRIETARY MARKETS, LLC: 82,727
RENAISSANCE TECHNOLOGIES LLC: 49,700
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 35,228
10.50% of PharmaCyte Biotech, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 912,124 shares in the last 24 months. This purchase volume represents approximately $1.40 M in transactions.